Gastroenterology Research and Practice / 2018 / Article / Tab 3 / Research Article
Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer Table 3 Univariate and multivariate analyses for disease-specific survival in patients after curative resection of gastric cancer.
Univariate analysis Multivariate analysis HR (95% CI) HR (95% CI) Age (for 10-year increase) 1.125 (1.076–1.176) <0.001 1.123 (1.073–1.175) <0.001 Male sex (vs. female sex) 0.979 (0.878–1.091) 0.699 Charlson index ≥ 3 (vs. 0–2) 1.126 (0.758–1.670) 0.557 ASA classification ≥ 3 (vs. 1–2) 1.212 (0.997–1.473) 0.054 Neoadjuvant chemotherapy (vs. no) 2.088 (1.557–2.799) <0.001 1.927 (1.436–2.587) <0.001 Tumor diameter (for 10 mm increase) 1.237 (1.217–1.258) <0.001 1.104 (1.082–1.126) <0.001 Tumor stage II (vs. stage I) 3.301 (2.485–4.385) <0.001 2.765 (2.076–3.683) <0.001 Tumor stage III (vs. stage I) 12.394 (9.703–15.831) <0.001 8.759 (6.778–11.318) <0.001 Open gastrectomy (vs. LG) 1.401 (1.273–1.543) <0.001 Total gastrectomy (vs. distal gastrectomy) 1.789 (1.619–1.978) <0.001 Proximal gastrectomy (vs. distal gastrectomy) 1.195 (0.857–1.667) 0.293 Operative time (for 30-minute increase) 1.109 (1.087–1.133) <0.001 Blood loss (for 50 mL increase) 1.069 (1.052–1.085) <0.001 Adjuvant chemotherapy (vs. no) 1.149 (1.047–1.261) 0.004 0.872 (0.791–0.962) 0.002 Surgical period 2006–2014 (vs. 1996–2005) 0.988 (0.894–1.092) 0.817 Postoperative complication (vs. no) 1.347 (1.189–1.526) <0.001 1.194 (1.051–1.357) 0.006